8 assets in Familial Amyloid Neuropathy

Therapeutic assets addressing Familial Amyloid Neuropathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tafamidis Familial Amyloid Neuropathy	Qilu Pharmaceutical Co., Ltd.	P4	A (87)
Inotersen Familial Amyloid Neuropathy	Akcea Therapeutics	P4	BB (70)
Acoramidis Familial Amyloid Neuropathy	Eidos Therapeutics, a BridgeBio company	P3	B (60)
Aln-Ttrsc02 Familial Amyloid Neuropathy	Alnylam Pharmaceuticals	P3	B (60)
Nexiguran Ziclumeran Familial Amyloid Neuropathy	Intellia Therapeutics	P3	B (60)
Nucresiran Familial Amyloid Neuropathy	Alnylam Pharmaceuticals	P3	B (60)
Eplontersen Familial Amyloid Neuropathy	Ionis Pharmaceuticals, Inc.	P3	NR ()
Yolt-201 Familial Amyloid Neuropathy	YolTech Therapeutics Co., Ltd	P1/2	NR ()